baber/WOPTO huggingface dataset:
Patent ES-540250-A0 (ES)
IPC: C12Q1/00
Filed: 1985-02-08
Abstract: The detection and/or identification of materials of interest, such as biological materials, e.g. chemically labeled DNA, which provide a receptor thereon, is improved by employing a heterologous detection system by employing more than one binding reactions, such as reactions involving the affinity of lectin to a glycoprotein or sugar group and the affinity between biotin and avidin or streptavidin, avidin itself being a glycoprotein. Particularly useful in the heterologous detection system are biotinylated lectins, such as biotinylated Concanavalin A, biotinylated dextran, lectingly-coprotein complexes, such as lectin-avidin and lectinenzyme complexes and streptavidin-biotinylated enzyme complexes. By way of example, the detection of single-stranded glycosylated DNA hybridized to complementary single-stranded DNA is detected by bringing the hybridized double-stranded DNA into contact with a lectin, such as Concanavalin A, for attachment to the glycosyl group of the glycosylated DNA, followed by contact with a biotinylated dextran, a polysaccharide, and then by contact with a lectin-enzyme complex, such as Concanavalin A-horseradish peroxidase or acid phosphatase. Also, there would be employed an enzyme complex comprising streptavidin-biotinylated horseradish peroxidase. The lectin-enzyme complex would attach itself to the sugar or saccharide of the biotinylated dextran which is also attached to the lectin which is fixed to the glycosyl groups of the hybridized DNA. The streptavidin-biotinylated enzyme complex would attach itself to the biotin moieties of the biotinylated dextran which, as indicated, is linked to the lectin attached to the glycosyl groups of the target double-stranded DNA.
Patent ES-540440-A0 (ES)
IPC: B29C67/00
Filed: 1985-02-15
Abstract: The present invention provides for a process for transforming a substantially continuous web of substantially planar, deformable material having an indefinite length, a first surface, and a second surface into a formed material. The material has a transofrmation temperature range. The process comprises the following steps:(a) The web of material is provided on a forming structure with the first surface of the web of material proximate a forming surface of the forming structure. The forming surface moves in a direction of the length of the web of material and carries the web of material in that direction.(b) A liquid stream is applied to the second surface of the web of material. The liquid stream has sufficient force and mass flux to cause the web of material to be deformed toward the forming surface, such that the material acquires a substantial three-dimensional conformation.(c) The temperature of the web of material is controlled such that it remains below the transformation temperature range of the material throughout the process.
Patent ES-546359-A0 (ES)
IPC: C07C275/54
Filed: 1985-08-23
Abstract: Novel benzoylaminophenylureas of the formula   <IMAGE>  wherein  R1 is hydrogen, halogen, CF3 or C1-C4alkoxy,  R2 is halogen, C1-C4alkyl, CF3 or C1-C4alkoxy,  R3 is hydrogen, halogen, CF3 or methyl,  R4 is fluorine or chloride,  R5 is hydrogen, fluorine or chlorine, R6 and R7 are each independently of the other C1-C6alkyl, C3-C5alkenyl, C3-C5alkynyl, or C1-C4-alkyl which is substituted by 1 to 8 fluorine or chlorine atoms or by methoxy or ethoxy; or R6 and R7, together with the nitrogen atom to which they are attached, are the radical   <IMAGE> are prepared from novel amines. Compositions containing the novel ureas are used for controlling insects and representatives of the order Acarina. The novel ureas have larvicidal action, in particular against plant-destructive insects.
Patent ES-547294-A0 (ES)
IPC: C07D273/00
Filed: 1985-09-25
Abstract: The invention relates to macropolycyclic rare earth complexes, namely cryptates which are useful as fluorescent tracers.
Patent ES-552753-A0 (ES)
IPC: B21B31/07
Filed: 1986-03-07
Abstract: Compensating device able to compensate the load acting on e upper bearings (13-17) of shafts of rolls (10) supported at only one end on rolling stands (18), such rolls (10) comprising shafts (11) having at least two bearings (13-14), an upper bearing (13) and a lower bearing (14), the device comprising springs (20) able to provide a resiliently yielding constraint between such bearings (13-14).
Patent ES-555444-A0 (ES)
IPC: C25C3/10
Filed: 1986-05-29
Abstract: The invention concerns a superstructure for a tank for the production of aluminum using the Hall-Heroult process by the electrolysis of alumina in molten cryolite, the tank being formed by a rigid metal heat-insulated casing of elongate parallelepipedic shape, the two ends of which are referred to as heads, and a superstructure formed by at least one rigid beam disposed along the long length of the casing, supporting in particular the anodic bus and the anodes and resting at its two ends on supports disposed at the two head ends of the tank, said superstructure being characterized in that each rigid beam is supported on at least one intermediate gantry in the central part thereof. The gantry may comprise four legs so as to constitute an inherently stable structure or it may be formed by two half-elements each provided with two legs. Preferably, each rigid beam is divided into two equal portions, the central ends of which are supported on the gantry.
Patent FI-861125-A0 (FI)
Inventor: LIPINSKI CHRISTOPHER ANDREW
IPC: C07D491/10
Filed: 1986-03-18
Abstract: PCT No. PCT/US84/01155 Sec. 371 Date Mar. 14, 1986 Sec. 102(e) Date Mar. 14, 1986 PCT Filed Jul. 20, 1984 PCT Pub. No. WO86/00807 PCT Pub. Date Feb. 13, 1986.Spiro-imidazolones are disclosed which are useful as aldose reductase inhibitors and as therapeutic agents for the treatment of complications arising from diabetes. Pharmaceutical compositions containing the spiro compounds and a method of treating diabetic complications are also disclosed.
Patent FI-864991-A0 (FI)
Inventor: WATANABE SUSAN MITSUE
IPC: C12N15/00
Filed: 1986-12-08
Abstract: Immunologically reactive gag proteins of LAV are expressed in bacterial cells. The gag proteins are encoded by a recombinant plasmid containing procaryotic trancriptional and translational signals for expression, followed downstream by a DNA sequence comprising a portion of the gag region of LAV. Preferred signals for expression are selected from an inducible and/or suppressible operon, such as the trp operon. The gag proteins are isolated from the bacterial host and are utilized in diagnostic assays which detect the presence of LAV antigens or antibodies immunologically reactive with LAV. Further, the proteins produced by the method disclosed may be used as a vaccine against infection by the causitive virus for acquired immune deficiency syndrome.
Patent FI-882697-A0 (FI)
Inventor: LEHTO ARI
IPC: G01N27/12
Filed: 1988-06-08
Abstract: A sensor for, e.g., the measurement of gas concentration, comprising a sensor element (8,10); a heating element (11) arranged in conjunction with the sensor, with which the sensor element can be brought to a temperature above the ambient gas atmosphere temperature; and an electronics circuitry section (18), with which the desired electronical properties of the sensor element (8,10) can be measured and the heating element (11) of the sensor (8,10) can be controlled. The sensor element (8,10) and the electronics circuitry (18) are on the same planar substrate which has openings around the sensor element area (8,10) to the immediate vicinity of the area so that the openings (5,13,17) extend through the substrate (1,7), whereby the sensor area (8,10) is connected to the surrounding part of the substrate and, thence, to the electronics circuitry section (18), only along thin isthmuses (14) remaining between the openings.
Patent FI-892005-A0 (FI)
Inventor: GERSHONI JONATHAN M
IPC: C07K14/705
Filed: 1989-04-27
Abstract: PCT No. PCT/US88/02991 Sec. 371 Date Jun. 30, 1989 Sec. 102(e) Date Jun. 30, 1989 PCT Filed Aug. 30, 1988 PCT Pub. No. WO89/01779 PCT Pub. Date Mar. 9, 1989Molecular decoyants are chemical structures which functionally resemble an endogenous receptor. They may be used for the treatment of humans or other animals which have been subjected to a foreign agent which exerts an undesired effect only after first binding to that endogenous receptor. A decoyant is a fraction of an endogenous receptor which retains the essential elements of the binding site of the receptor for the foreign agent or is a synthetic or biosynthetic derivative thereof. The  alpha 184-200 amino acid sequence of Torpedo californica acetylcholine receptor is an example of a decoyant which protects against curarimimetic neurotoxins. Another example is the fraction of the CD4 receptor which retains the essential elements of the receptor for protection against HIV.
Patent FI-892592-A0 (FI)
Inventor: REY LOUIS
IPC: A23F5/26
Filed: 1989-05-26
Abstract: A process for the preparation of plant extracts under mild conditions, especially of high-quality coffee extract by multistage cold extraction of ground roast coffee is described. A high overall yield can be achieved by stepwise milling of the solid constituents in aqueous suspension down to colloidal fineness in the second and third extraction stage at low temperatures. The residue can, where appropriate, be subjected to a short-term high-temperature treatment.
Patent FI-905807-A0 (FI)
Inventor: MARZ DANIEL
IPC: H04N7/10
Filed: 1990-11-26
Abstract: A carrier is received containing a plurality of signals within a first frequency band, for example television signals within the cable television band. The signals are upconverted to a second frequency band above the first band wherein a selected one of the upconverted signals will reside at an intermediate frequency within the second band. The selected upconverted signal is input to a homodyne detector operating at or near intermediate frequency. In-phase and quadrature signals output from the homodyne detector are digitally processed to recover a baseband signal. <IMAGE>
Patent FI-911986-A0 (FI)
Inventor: CHAKRABARTI JIBAN KUMAR
IPC: A61P43/00
Filed: 1991-04-24
Abstract: 2-Methyl-10-(4-methyl-1-piperazinyl)-4H-thieno-[2,3-b][1,5]benzodiazep ine, or an acid salt thereof, has pharmaceutical properties, and is of particular use in the treatment of disorders of the central nervous system.
Patent FI-913894-A0 (FI)
Inventor: FOBARE WILLIAM FLOYD
IPC: C07D405/12
Filed: 1991-08-16
Abstract: The compounds of the formula: <CHEM> in which X, and Y are, independently, hydrogen, halogen, hydroxy, nitro, cyano, carboxyl, trifluoromethyl, phenyl, amino, alkylamino, dialkylamino, alkyl, alkoxy or phenylalkyloxy; R1 is hydrogen, alkyl, hydroxyalkyl, alkenyl, cycloalkyl, phenylcycloalkyl, 1-hydroxymethylphenethyl, 1-(t-butyl)dimethylsilyloxymethylphenethyl, 1-(t-butyl)dimenthylsilyloxy methylisopentyl, 1-hydroxymethylisopentyl, phenyl, benzyl or substituted phenyl or benzyl, where the substituents are alkyl, alkoxy, halogen, cyano, trifluoromethyl, amino, alkylamino, dialkylamino, nitro or phenyl, benzyl, phenethyl or R1 is thienyl, imidazolyl, thiazolyl, pyridinyl, pyrimidinyl, pyrazinyl, benzamidazolyl, phenylalkylpiperidinyl or morpholino; R2 is alkyl, cycloalkyl, phenyl, benzyl or substituted phenyl or benzyl in which said substituent is alkyl, alkoxy, halogen, cyano, trifluoromethyl amino, nitro, alkylamino or dialkylamino; and a pharmaceutically acceptable salt thereof; are ACAT inhibitors, some of which possess antioxidant properties.
Patent FI-914360-A0 (FI)
Inventor: CANDRIES PAUL
IPC: C08L27/06
Filed: 1991-09-17
Abstract: The plurimodal latices are produced by polymerisation of vinyl chloride in nonmicellar aqueous emulsion in the presence of a seed consisting of a plurimodal latex originating from a preceding polymerisation cycle. The mean size of the elementary particles of the plurimodal latices produced is identical with that of the elementary particles of the seed. The latter preferably consists of three classes of elementary particles which have mean diameters of between 0.15-0.30  mu m, between 0.45-0.60  mu m and between 1.05-1.25  mu m respectively. 
<??>The vinyl chloride polymers originating from the plurimodal latices are particularly suitable for the manufacture of low-viscosity plastisols.
Patent FI-925161-A0 (FI)
Inventor: DEMMELER LUDWIG
IPC: B25H1/08
Filed: 1992-11-13
Abstract: Stud (81) for detachably connecting a component (82, 83), provided with through-holes or the like, to a further component, such as a table, likewise provided with through-holes, the through-holes being circular or slot-shaped in cross-section and having cylindrical or parallel walls. The stud (81) is provided with an axially running threaded spindle (95) which is connected in a rotationally locked manner to a handle (84) or the like led out to the outside. This handle is provided as an outer clamping means, while the threaded spindle (95) is provided at its other end with a stem (97) or the like which acts on catch means (balls 91) which can be pushed out of the stud (81) in the radial direction. <IMAGE>
Patent FI-943612-A0 (FI)
Inventor: NISS JAN-ANDERS
IPC: B67D1/00
Filed: 1994-08-03
Abstract: PCT No. PCT/SE93/00014 Sec. 371 Date Aug. 3, 1994 Sec. 102(e) Date Aug. 3, 1994 PCT Filed Jan. 13, 1993 PCT Pub. No. WO93/14679 PCT Pub. Date Aug. 5, 1993A dispensing device for flowing substances, especially food substances, comprises a valve arrangement (2) for controlling flow of substance from a container (3) out through a discharge opening (4). The container (3) is of the type that decreases its volume at the same rate as with which the substance is discharged from the container in order to avoid that the substance in the container there gets in contact with air. Between the valve arrangement (2) and the container (3) a conduit (6)is extending, which is co-ordinated with a pump arrangement (7) arranged to transport the substance in the conduit without getting in direct contact with the substance.
Patent FI-950602-A0 (FI)
Inventor: KNOX ROBERT BRUCE
IPC: A61K38/08
Filed: 1995-02-10
Abstract: The present invention provides isolated peptides of Lol p V, a major protein allergen of the species Lolium perenne. Therapeutic peptides within the scope of the invention comprise at least on T cell epitope, or preferably at least two T cell epitopes of a protein allergen of Lol p V. Diagnostic peptides within the scope of the invention bind IgE. The invention also provides modified peptides having similar or enhanced therapeutic properties as the corresponding, naturally-occurring allergen or portion thereof, but having reduced side effects. The invention further provides nucleic acid sequences coding for peptides of the invention. Methods of treatment or diagnosis of sensitivity to Lol p V or an allergen immunologically related to Lol p V in an individual. Therapeutic compositions comprising one or more peptides of the invention are also provided.
Patent FI-954270-A0 (FI)
Inventor: MEISSNER HANS-MICHAEL
IPC: F02B3/06
Filed: 1995-09-12
Abstract: An auxiliary propulsion system that can be combined with a diesel engine to drive the shaft. A retrofittable diesel engine with a generator is installed to operate an electric motor. The electric motor is coupled to the shaft by means of a transmission with a flexible coupling and a clutch.
Patent FI-954539-A0 (FI)
Inventor: SAITO YUTAKA
IPC: A24B3/12
Filed: 1995-09-25
Abstract: A smoking article (10) contains a flavor component retainer obtained by heating and gelling a mixture of a flavor component and a non-gelled glucan and containing heat-irreversibly gelled glucan, and a flavor generation material containing the flavor component retained by this retainer as a combustion smoking raw material (12). Since the flavor component is firmly fixed and retained inside a three-dimensional network structure of gelled glucan, preservability and emission durability of the flavor component can be improved. <MATH>
Patent FI-963701-A0 (FI)
Inventor: PORTMANN RUDOLF
IPC: G01N33/15
Filed: 1996-09-18
Abstract: PCT No. PCT/CH95/00055 Sec. 371 Date Sep. 18, 1996 Sec. 102(e) Date Sep. 18, 1996 PCT Filed Mar. 13, 1995 PCT Pub. No. WO95/25955 PCT Pub. Date Sep. 28, 1995The invention concerns a method for determining the toxicity of water-soluble substances or of substances which can be mixed with water and thus obtaining quantitative information concerning the toxic effect of said substances. The invention helps to reduce the number of tests, necessary hitherto, performed on mammals. According to the method, at least two measurements determine the variation in mobility and/or size of test organisms in an aqueous medium, under the influence of at least one toxic substance. A device for carrying out the method comprises an image-detection unit which detects the object and sequentially records images of this object in at least one plane at predetermined time intervals. Arranged downstream of the image-detection unit is an evaluation arrangement with a computer and display devices which statistically evaluate the mobility and/or size of the organisms in relation to the existing toxicity. The method is used in particular for determining toxic influences on the environment, in particular water fauna, and for determining side-effects and contra-indications of pharmaceuticals and foodstuffs.
Patent IL-64917-A0 (IL)
Title: Clasp or fastener for jewellery
IPC: A44C/
Filed: 1982-02-02
Abstract: A fastener for jewelry and the like comprises a box-shaped structure made of foil and has, at both ends, two transverse seats which receive fastening elements of a chain or the like to which the fastener is attached. One end is formed by a half-open hook which is closed by a resiliently mounted tongue forming part of the box-shaped structure. The tongue is shaped to increase its stiffness so that the fastener will not become unfastened accidentally despite the fact that the foil is of soft metal such as gold.
Patent IL-75575-A0 (IL)
Title: Synthesis of 2,2,2-trifluoroethanol and 1,1,1,3,3,3-hexafluoroisopropyl alcohol
IPC: C07C29/136
Filed: 1985-06-19
Abstract: A process for producing 2,2,2-trifluoroethanol or 1,1,1,3,3,3-hexafluoroisopropanol which comprises hydrogenating a fluoro compound having the formula   <IMAGE>   wherein R1 is hydrogen or CF3 and R2 is hydrogen or a straight- or branched-chain alkyl group, which can also be fluoro-substituted, in the liquid phase in the presence of a palladium-on-activated-carbon catalyst, and if desired a tertiary amine co-catalyst.
Patent IL-78022-A0 (IL)
Title: Stabilized solutions of 5-chloro-3-isothiazolones
IPC: A61K8/34
Filed: 1986-03-03
Abstract: 5-Chlor-3-isothiazolones are stabilized against chemical decomposition in non-aqueous solution using organic hydroxy solvent and, optionally, stabilization salt when the contents of the components are 0.5 to 10% isothiazolone, 89 to 99.5% hydroxy solvent and 0 to 1% stabilization salt, the percentages being by weight of the three stated components, the hydroxy solvent comprising one or more solvents of the formulae: <CHEM> wherein R and R<1> are hydrogen or lower alkyl, X is -CH2OCH2-or -(CH2)n- wherein n is an integer of 1 to 4 and y is an integer of 1 to 150. These compositions exhibit biocidal and preservative properties.
Patent IL-87487-A0 (IL)
Title: Opaque tinting of contact lenses
IPC: B29D11/00
Filed: 1988-08-18
Abstract: In opaquing and tinting a contact lens, an opaquing medium is deposited on the lens anterior surface as discrete randomly sized, randomly positioned droplets from a fine mist spray of the medium so that the ultimately formed opaque covering on the lens will correspond in appearance with the random droplet pattern. Mist spray apparatus also is provided.
Patent IL-89503-A0 (IL)
Title: Taxol derivatives,pharmaceutical compositions containing the same and process for the preparation thereof
IPC: A61K31/40
Filed: 1989-03-06
Abstract: Antineoplastic, water soluble, taxol derivatives and methods for preparing the same are described.
Patent IL-97143-A0 (IL)
Title: Electrical connection
IPC: C09J177/00
Filed: 1991-02-04
Abstract: PCT No. PCT/GB91/00175 Sec. 371 Date Aug. 6, 1992 Sec. 102(e) Date Aug. 6, 1992 PCT Filed Feb. 6, 1991 PCT Pub. No. WO91/12638 PCT Pub. Date Aug. 22, 1991.An assembly for forming a semi-permanent electrical connection between a pair of wires (1,2) comprises a male push-fit connector (3) and a female push-fit connector (4). Each connector (3,4) has a connection part to enable it to be connected to the wire, e.g. in the form of a crimp (5,6) and a mating part for engagement to the other connector. Each of the connectors has a sealing jacket (8,10) for sealing the connection to the associated wire, and one of the connectors has a heat-recoverable skirt (11) which, when the connectors are engaged, extends over part of the sealing jacket of the other connector to seal the connection against moisture ingress. The skirt (11) is provided with a layer of adhesive for forming the seal.
Patent IL-98745-A0 (IL)
Title: Thioalkylthio cephalosporins
IPC: C07D501/59
Filed: 1991-07-05
Abstract: Novel compounds of the formula I:    QSR<2>SR<1>Het   wherein Q is C1-C12 acyl or halogen; R<1> is a single bond or C1-C4 alkylene; and R<2> is a straight or branched C1-C4 alkylene; Het is 1,2,3-triazol-4-yl, or a derivative which is optionally protected at a nitrogen atom. The novel compounds are useful as intermediates for the production of thioalkylthio cephalosporin antibiotic compounds.
Patent IL-99940-A0 (IL)
Title: Beta-galactoside binding proteins,methods for the production thereof,and pharmaceutical compositions containing the same
IPC: C12N15/09
Filed: 1991-11-01
Abstract: PCT No. PCT/GB91/01898 Sec. 371 Date Apr. 30, 1993 Sec. 102(e) Date Apr. 30, 1993 PCT Filed Oct. 30, 1991 PCT Pub. No. WO92/07938 PCT Pub. Date May 14, 1992Non-agglutinating  beta -galactoside binding proteins (GBP), both the natural proteins and proteins produced by recombinant DNA technology, are provided for use as inhibitors and regulators of vertebrate cell growth and as anti-viral agents. Methods of producing the GBP's are also described. The GBP's show a powerful growth inhibitory effect against human cancer cells making them potentially useful therapeutic agents in the treatment of malignant disease and also show an inhibitory effect on viral replication making them potentially useful as anti-viral agents.
Patent AU-PO591997-A0 (AU)
Title: Improvements in a process and apparatus for the production of paper products
IPC: C10L5/44
Filed: 1997-03-27
Abstract: A process and an apparatus for the production of paper products, such as "cat litter" or paper fuel, comprising reducing paper to a particulate form by shredding and grinding, conveying the particles of paper from a hopper as a layer on a first conveyor firstly beneath a leveling and compacting roller and thereafter beneath a set of water sprayers, before discharging from the conveyor onto a second conveyor with the assistance of a rearwardly baffle plate to invert the layer during transfer. The inverted layer on the second conveyor passes to a third conveyor belt which moves through a ring with has the effect of wrapping the belt over itself and around the mix to form a tunnel enveloping and compacting the mix to form an extrusion. The paper product as extruded is cut into pellets before subjecting the pellets to dehydration. In the case of paper product to be used as paper fuel, the paper is mixed with coal dust. The bottom of the hopper contains a plurality of rotatable worm screws for discharging the paper evenly across the conveyor while rotatable paddle agitators are also contained in the bottom of the conveyor to prevent the particulate paper from agglomerating into lumps.